Short-Term Endocrine Pause for Pregnancy Safe in Early HR+ Breast Cancer
Halle Moore, MD, discusses findings from a study on young breast cancer survivors who attempted pregnancy after interrupting hormone therapy.
Long-Term Results Show Comparable Efficacy for Anastrozole and Tamoxifen
Halle Moore, MD, discusses the results of the IBIS-II DCIS trial of anastrozole versus tamoxifen after 12 years of follow-up for postmenopausal patients with locally excised ductal carcinoma in situ.
Reducing the Risk of Premature Ovarian Failure With LHRH Analog Administration With Chemotherapy in Breast Cancer
Halle Moore, MD, discusses a phase III trial that looked at reducing the risk of premature ovarian failure with LHRH analog administration with chemotherapy in women with breast cancer.